Jeevtronics

Medical Devices and Products

CURRENT IMPACT

As on November 2022

230+

defibrillators deployed

30%

devices deployed in Tier 2 and 3 Towns

Geographical Focus
  • PAN India
Potential Impact
  • Reach

    1.5 million


    lives

Samridh support

SAMRIDH’s initial partnership with Jeevtronics entailed providing financial assistance to enhance the sales and distribution activities of SanMitra 1000 HCT Biphasic Defibrillator. This support has been further complemented with business advisory services to help Jeevtronics in designing a commercial strategy to increase its market presence and build a steady pipeline of orders. These initiatives have further enabled them to secure affordable working capital loans from financial institutions to service the new order flow and achieve a business model for long-term sustainability and expansion to low-resourced hospitals.

660,000

deaths, per year occur in India due to sudden cardiac arrest[1]

16.7
%

COVID-19 patients suffer from arrhythmias, a condition causing irregular or abnormal heart beats[2]

1
in
50

ICU beds have a defibrillator[3]

Sudden Cardiac Arrest (SCA) is a condition where the heart suddenly stops, leading to a person’s death. In addition, COVID-19 patients who suffer a sudden cardiac arrest, either in or out of hospitals, are far more likely to die than those not infected with the coronavirus. To deal with cardiac arrests and arrhythmias, a medical device called ‘Defibrillator’ helps restore the normal heart rhythm by applying a high voltage shock across the heart. However, most hospitals in India do not have access to a defibrillator. In addition, India accounts for the highest global deaths in road accidents. Since accident trauma patients are more likely to go into cardiac arrest, the presence of defibrillators in trauma ambulances is critical. Yet, only about 25% of total ambulances have defibrillators.

[1] Rao B. H. (2014). Global burden of Sudden Cardiac Death and insights from India. Indian heart journal, 66 Suppl 1(Suppl 1), S18–S23.

[2] Wang D, Hu B, Hu C, et al.Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. Published online February 07, 2020.

[3] Grassroots Innovation Database by United Nations Development Programme (UNDP) India and Honeybee Network

World’s first triple-powered cost-effective defibrillator

Lack of reliable electricity, high-battery replacement costs, poor quality of refurbished devices, and lack of affordability are primary causes for the inadequate access to defibrillators in India. Jeevtronics offers a low maintenance, cost-effective, lifesaving, hand-cranked defibrillator – SanMitra 1000 HCT Biphasic Defibrillator. It can be charged from the AC mains within 6-7 seconds and is priced at less than 25% of conventional defibrillators. SAMRIDH’s support is enabling Jeevtronics to increase accessibility to this life-saving device in resource-constrained hospitals in semi-urban and rural areas. Its longevity, affordability, and ability to operate without electricity enables healthcare workers to provide quality care and avoid preventable deaths. Jeevtronics is also working on product upgrades for ambulances and IoT-enabled models to maximize the benefits, resulting in overall cost savings for the end-user.